Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

DECEMBER 6, 2023

and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today provided additional information regarding a March 2022 licensing and collaboration agreement between Philochem and Blue Earth Diagnostics. Chief Executive Officer of Blue Earth Diagnostics.

Diagnostic 93

Diagnostic Diagnostic Imaging Clinic Radiopharmaceuticals 93

UCSF Biomedical Imaging

JANUARY 12, 2024

In 2003, the Center for Molecular and Functional Imaging (CMFI) at China Basin Landing opened its doors with San Francisco’s first 3T MRI and two 1.5T clinical scanners, followed a few years later by a cyclotron which launched our in-house radiopharmaceutical program.

Radiopharmaceuticals 122

Radiopharmaceuticals Imaging MRI Clinic 122

Imaging Technology

SEPTEMBER 20, 2023

a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX biology-guided radiotherapy.

Pharmaceutical 94

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 94

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 84

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 84

Imaging Technology

SEPTEMBER 8, 2023

milla1cf Fri, 09/08/2023 - 16:25 September 8, 2023 — Positron Corporation , a leading molecular imaging medical device company, is pleased to announce that the Company will begin its clinical study of its Affinity PET-CT imaging device with Ochsner Clinic Foundation in New Orleans, LA. on September 18, 2023.

Clinic 92

Clinic Radiopharmaceuticals Medical Device IT 92

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 78

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 78

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 86

Radiopharmaceuticals Imaging Disease Diagnostic 86

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

NOVEMBER 26, 2023

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy.

Clinic 54

Clinic Radiopharmaceuticals Radiosensitivity Pharmaceutical 54

Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 73

Pharmaceutical Radiopharmaceuticals Clinic Medical 73

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 79

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 79

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., Siegel told AuntMinnie.com. "My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

AuntMinnie

DECEMBER 8, 2023

Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported. The bottom line?

Imaging 119

Imaging Radiopharmaceuticals Disease Diagnose 119

AuntMinnie

JUNE 5, 2024

NorthStar Medical Radioisotopes has completed a cleanroom facility at its campus in Beloit, WI, to support batch production of radiopharmaceuticals for research and treatment. The cleanroom at NorthStar's campus in Beloit, WI.

Radiopharmaceuticals 52

Radiopharmaceuticals Clinic Medical IT 52

AuntMinnie

JUNE 19, 2024

Voximetry now offers nuclear medicine dosimetry technology as a remote service, with its recent launch of RPT Dosimetry Clinical Services. Incorporating radiopharmaceutical therapy dosimetry typically requires advanced, in-house software, and a trained physics staff, Voximetry said.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Clinic Imaging 52

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

AuntMinnie

MAY 30, 2023

Read more on AuntMinnie.com Related Reading: Blue Earth touts clinical results Blue Earth highlights results from PET tracer trial PET tracer shows promise in imaging of brain tumors Blue Earth touts PSMA radiotracer study Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

Radiopharmaceuticals 52

Radiopharmaceuticals Imaging Diagnostic Clinic 52

Imaging Technology

JULY 28, 2023

It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology. We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. POSLUMA was approved by the U.S.

Clinic 81

Clinic Diagnostic Radiopharmaceuticals Radiation 81

Imaging Technology

JUNE 11, 2024

She will also raise awareness of nuclear medicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Patient Care Medical 52

Imaging Technology

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 10:00 December 12, 2023 — IBA , a world leader in particle accelerator technology and of radiopharmaceutical production solutions is pleased to announce the start of the installation of a Cyclone 30XP in Poland. Beyond At-211, IBA is also pioneering novel accelerator applications for other theranostic isotopes.

Radiopharmaceuticals 109

Radiopharmaceuticals Nuclear Medicine Clinic IT 109

Imaging Technology

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:57 June 7, 2024 — Shine Technologies, LLC , a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics , a Bracco company and recognized leader in the development of innovative radiopharmaceuticals. Statistically, approximately 12.9%

IT 82

IT Radiopharmaceuticals Clinic Diagnose 82

AuntMinnie

JUNE 20, 2024

F-18 fluorocholine (FCH) PET/CT could be a first-line technique over technetium-99m sestamibi (Tc-99m MIBI) SPECT/CT for imaging parathyroid tumors prior to surgery, according to a study published June 20 in JAMA Otolaryngology-Head & Neck Surgery. No complications occurred. The full study is available here.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Imaging Clinic 105

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He completed a postdoctoral fellowship in molecular imaging at Memorial Sloan Kettering Cancer Center. He will be honored at the SNMMI's annual meeting in Toronto.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 122

Imaging Technology

MAY 2, 2023

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 PET imaging currently under review by the U.S.

Diagnostic 89

Diagnostic Radiopharmaceuticals Imaging Radiation 89

AuntMinnie

JANUARY 19, 2024

The promise of imaging One challenge is that advances in Alzheimer’s care can only help people if they are reaching the right patients at the right time in their patient journey. Reimbursement barriers Unfortunately, until recently, there were significant barriers to receiving amyloid PET imaging in some regions.

Disease 52

Disease Medicare Imaging PET Scan 52

TTG Imaging Solutions

MAY 5, 2023

Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiation oncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. Digirad Health, Inc.

Imaging 52

Imaging Radiopharmaceuticals Radiation Oncology Nuclear Medicine 52

TTG Imaging Solutions

FEBRUARY 17, 2022

Imaging Conference & Expo: February 20 – 22, 2022 TTG Imaging Solutions will be exhibiting at the Imaging Conference & Expo in Napa, CA. Be sure to visit us at booth #304 Monday, February 21 and Tuesday, February 22 to discover solutions for equipment, nationwide service, parts, and clinical support.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

Imaging Technology

JANUARY 12, 2024

“We are grateful that CMS recognizes the potential of our SCINTIX therapy for patients with all stages of indicated cancers and, with this decision, has addressed provider payment as a barrier to clinical adoption,” continued Powell. Patient treatments also began at several clinical sites in 2023. 1, 2024, to describe SCINTIX therapy.

Radiopharmaceuticals 98

Radiopharmaceuticals Radiation Medicare Clinic 98

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.

Diagnostic 72

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 72

AuntMinnie

MARCH 25, 2024

PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say. The game-changer could be the pending U.S. approval of new PET radiotracers, such as F-18 flurpiridaz , he said.

Nuclear Medicine 128

Nuclear Medicine Radiopharmaceuticals Disease Radiation 128

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 88

Medical Radiopharmaceuticals Pharmaceutical Radiation 88

Imaging Technology

MAY 14, 2024

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. This alliance will help UH expand patient access and transform cancer care from discovery to recovery.

Hospital 100

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 100

AuntMinnie

JUNE 27, 2023

Read more on AuntMinnie.com Related Reading: FDA approves new PET tracer for prostate cancer imaging Blue Earth touts clinical results PET tracer shows promise in imaging of brain tumors Blue Earth touts PSMA radiotracer study Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

Radiopharmaceuticals 52

Radiopharmaceuticals Diagnostic Clinic Imaging 52

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit.

Medical 79

Medical Radiopharmaceuticals Pharmaceutical Radiation 79